Literature DB >> 23044417

Defective ER associated degradation of a model luminal substrate in yeast carrying a mutation in the 4th ER luminal loop of Sec61p.

Matthew C Wheeler1, Nicholas Gekakis.   

Abstract

The major constituent of the eukaryotic ER protein-translocation channel (Sec61p in yeast, Sec61α in higher eukaryotes) shows a high degree of evolutionary conservation from yeast to humans. The vast majority of eukaryotic species have a conserved di-tyrosine in the 4th ER luminal loop. Previously, we discovered through a screen of ethylnitrosourea- (ENU-) mutagenized mice that substitution of the latter of these tyrosines with histidine (Y344H) of the murine Sec61α protein results in diabetes and hepatic steatosis in mice that is a result of ER stress. To further characterize the mechanism behind ER stress in these mice we made the homologous mutation in yeast Sec61p (Y345H). We found that this mutation increased sensitivity of yeast to ER stressing agents and to reduction of Inositol Requiring Enzyme 1 (IRE1) activity. Furthermore, we found that, while this mutation did not affect translocation, it did delay degradation of the model ER-associated degradation (ERAD) substrate CPY(∗). Replacing both ER luminal tyrosines with alanines resulted in a destabilization of the Sec61 protein that was rescued by over expression of Sss1p. This double mutant still lacked a noticeable translocation defect after stabilization by Sss1p, but exhibited a similar defect in CPY(∗) degradation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23044417      PMCID: PMC3490007          DOI: 10.1016/j.bbrc.2012.09.136

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Subunits of the translocon interact with components of the oligosaccharyl transferase complex.

Authors:  Manasi Chavan; Aixin Yan; William J Lennarz
Journal:  J Biol Chem       Date:  2005-04-14       Impact factor: 5.157

2.  A complex of Yos9p and the HRD ligase integrates endoplasmic reticulum quality control into the degradation machinery.

Authors:  Robert Gauss; Ernst Jarosch; Thomas Sommer; Christian Hirsch
Journal:  Nat Cell Biol       Date:  2006-07-16       Impact factor: 28.824

3.  A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins in vivo.

Authors:  I Stagljar; C Korostensky; N Johnsson; S te Heesen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

4.  The medial-Golgi ion pump Pmr1 supplies the yeast secretory pathway with Ca2+ and Mn2+ required for glycosylation, sorting, and endoplasmic reticulum-associated protein degradation.

Authors:  G Dürr; J Strayle; R Plemper; S Elbs; S K Klee; P Catty; D H Wolf; H K Rudolph
Journal:  Mol Biol Cell       Date:  1998-05       Impact factor: 4.138

5.  Split ubiquitin as a sensor of protein interactions in vivo.

Authors:  N Johnsson; A Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

6.  Der3p/Hrd1p is required for endoplasmic reticulum-associated degradation of misfolded lumenal and integral membrane proteins.

Authors:  J Bordallo; R K Plemper; A Finger; D H Wolf
Journal:  Mol Biol Cell       Date:  1998-01       Impact factor: 4.138

7.  Interaction of calmodulin with Sec61α limits Ca2+ leakage from the endoplasmic reticulum.

Authors:  Frank Erdmann; Nico Schäuble; Sven Lang; Martin Jung; Alf Honigmann; Mazen Ahmad; Johanna Dudek; Julia Benedix; Anke Harsman; Annika Kopp; Volkhard Helms; Adolfo Cavalié; Richard Wagner; Richard Zimmermann
Journal:  EMBO J       Date:  2010-11-23       Impact factor: 11.598

8.  SSS1 encodes a stabilizing component of the Sec61 subcomplex of the yeast protein translocation apparatus.

Authors:  Y Esnault; D Feldheim; M O Blondel; R Schekman; F Képès
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

9.  A point mutation in Sec61alpha1 leads to diabetes and hepatosteatosis in mice.

Authors:  David J Lloyd; Matthew C Wheeler; Nicholas Gekakis
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

10.  Sec61p is required for ERAD-L: genetic dissection of the translocation and ERAD-L functions of Sec61P using novel derivatives of CPY.

Authors:  Martin Willer; Gabriella M A Forte; Colin J Stirling
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

View more
  6 in total

1.  Hsp90 modulates PPARγ activity in a mouse model of nonalcoholic fatty liver disease.

Authors:  Matthew C Wheeler; Nicholas Gekakis
Journal:  J Lipid Res       Date:  2014-06-13       Impact factor: 5.922

2.  ERAD and protein import defects in a sec61 mutant lacking ER-lumenal loop 7.

Authors:  Thomas Tretter; Fábio P Pereira; Ozlem Ulucan; Volkhard Helms; Susanne Allan; Kai-Uwe Kalies; Karin Römisch
Journal:  BMC Cell Biol       Date:  2013-12-06       Impact factor: 4.241

3.  Proteasome 19S RP binding to the Sec61 channel plays a key role in ERAD.

Authors:  Marie-Luise Kaiser; Karin Römisch
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

4.  A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α-XBP1 Activation.

Authors:  Zhifen Yang; Jing Zhang; Dadi Jiang; Purvesh Khatri; David E Solow-Cordero; Diego A S Toesca; Constantinos Koumenis; Nicholas C Denko; Amato J Giaccia; Quynh-Thu Le; Albert C Koong
Journal:  Mol Cancer Res       Date:  2018-02-09       Impact factor: 5.852

5.  Analysis of Sec61p and Ssh1p interactions in the ER membrane using the split-ubiquitin system.

Authors:  Carol Harty; Karin Römisch
Journal:  BMC Cell Biol       Date:  2013-03-11       Impact factor: 4.241

6.  Transcriptomic Analysis of Pichia pastoris (Komagataella phaffii) GS115 During Heterologous Protein Production Using a High-Cell-Density Fed-Batch Cultivation Strategy.

Authors:  Chengbo Zhang; Yu Ma; Huabiao Miao; Xianghua Tang; Bo Xu; Qian Wu; Yuelin Mu; Zunxi Huang
Journal:  Front Microbiol       Date:  2020-03-20       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.